China Growth Trajectory: Mindray Sees Boost From Private Hospital Push
This article was originally published in PharmAsia News
Executive Summary
Chinese global medtech player Mindray posted single-digit growth in the fourth quarter, but stressed that business looks solid, due to growing demand from booming private and county hospitals in China.